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Abstract
Background: Despite significant investments into health improvement programmes in Uganda, health indicators
and access to healthcare remain poor across the country. The PRIME trial aims to evaluate the impact of a complex
intervention delivered in public health centres on health outcomes of children and management of malaria in rural
Uganda. The intervention consists of four components: Health Centre Management; Fever Case Management;
Patient- Centered Services; and support for supplies of malaria diagnostics and antimalarial drugs.
Methods: The PROCESS study will use mixed methods to evaluate the processes, mechanisms of change, and
context of the PRIME intervention by addressing five objectives. First, to develop a comprehensive logic model
of the intervention, articulating the project’s hypothesised pathways to trial outcomes. Second, to evaluate the
implementation of the intervention, including health worker training, health centre management tools, and
the supply of artemether-lumefantrine (AL) and rapid diagnostic tests (RDTs) for malaria. Third, to understand
mechanisms of change of the intervention components, including testing hypotheses and interpreting realities
of the intervention, including resistance, in context. Fourth, to develop a contextual record over time of factors
that may have affected implementation of the intervention, mechanisms of change, and trial outcomes, including
factors at population, health centre and district levels. Fifth, to capture broader expected and unexpected impacts
of the intervention and trial activities among community members, health centre workers, and private providers.
Methods will include intervention logic mapping, questionnaires, recorded consultations, in-depth interviews, focus
group discussions, and contextual data documentation.
Discussion: The findings of this PROCESS study will be interpreted alongside the PRIME trial results. This will enable
a greater ability to generalise the findings of the main trial. The investigators will attempt to assess which methods
are most informative in such evaluations of complex interventions in low-resource settings.
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Keywords: Process evaluation, Theory-driven evaluation, Pathways of change, Complex interventions, Cluster
randomised trial
* Correspondence: clare.chandler@lshtm.ac.uk
1Department of Global Health and Development, London School of Hygiene
& Tropical Medicine, 15-17 Tavistock Place, WC1H 9SH, London, UK
Full list of author information is available at the end of the article
Implementation
Science
© 2013 Chandler et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Chandler et al. Implementation Science 2013, 8:113
http://www.implementationscience.com/content/8/1/113
Background
The majority of developing countries are not on target
to achieve Millennium Development Goals four and five:
to reduce the mortality rate of children under five by
two-thirds and the maternal mortality ratio by three-
quarters between 1990 and 2015 [1]. Malaria is a key focus
for achieving these goals, with the latest World Health
Organisation (WHO) guidelines promoting access to
improved case management, including diagnostic testing
for all suspected cases [2]. Failure to reach health targets
has often been blamed on ‘health system bottlenecks’
[1,3], typically cited as inadequate numbers, quality and
distribution of health workers, equipment, supplies, and
infrastructure [4]. In addition, some have argued that the
way health services and programs are enacted in practice
is a social as well as a structural issue; a function of inter-
actions between clients, communities, health workers, and
systems [5,6].
In spite of significant investments in Uganda since the
early 1990s into programmes intended to improve health
and access to quality healthcare, health outcomes remain
poor across the country [7]. This poor progress has been
attributed by some to a lack of alignment between exter-
nally defined programme priorities, and the priorities of
local populations [8-12]. A more comprehensive approach
to healthcare is called for to improve management of
malaria and other febrile illnesses, attract patients to seek
care, and produce health benefits at the population level.
Reviews of empirical research suggest that simple inter-
ventions to improve access to quality malaria care such as
basic training or health education have had limited effect
on changing healthcare provider behaviour [13,14] or
the behaviour of populations [15]. Achieving a change
in behaviour may require complex interventions that
address the multiple factors involved with delivery of
appropriate treatment [16,17]. After undertaking formative
research in Tororo, eastern Uganda, to understand local
realities and aspirations for quality of care, an intervention
package was designed to improve access to good quality
healthcare for the local population [18]. The PRIME
intervention consists of four components: workshops in
Health Centre Management for health workers in-charge
of facilities; training and supervision visits in Fever Case
Management for all health workers; workshops in Patient
Centered Services for all health workers; and support
of supply of artemether-lumefantrine (AL) and rapid
diagnostic tests (RDTs) when stocks run low. Table 1
shows the topics for each module covered in the PRIME
intervention. The manuals for delivering the intervention
are available online at www.actconsortium.org.
The primary and secondary outcomes of the PRIME
intervention are being evaluated in a cluster-randomised
trial comparing health centres that receive the interven-
tion with ‘standard care’ health centres that do not receive
the intervention. The PRIME trial is evaluating outcomes
on three levels: an annual cross-sectional community
survey will assess the impact of the intervention on key
population-based health indicators in children under fif-
teen, with the primary outcome as prevalence of anaemia
in children under five; a cohort study will assess the
impact of the intervention on key longitudinal indica-
tors in children under five, with antimalarial treatment
incidence density as the primary outcome; and patient
exit interviews will assess the impact of the intervention
on key indicators of case management for malaria and
other illnesses in children under five treated at health
centres, with the primary outcome as inappropriate
treatment of malaria. The timing of the PRIME evaluation
activities can be seen in Figure 1 and further details of the
trial protocol can be found elsewhere [19].
Many researchers are now arguing for more compre-
hensive evaluations of complex interventions that attend
to implementation, mechanisms of change, and context
[20]. Such evaluations have been uncommon, and many of
those that have existed alongside randomised controlled
trials have been critiqued for poor integration with
quantitative findings and methodological limitations [21],
prompting the challenge for more carefully planned evalu-
ations. In the PROCESS study, we adopt a theory-driven
approach to our evaluation, aiming to understand what
the PRIME intervention was and what it did, and aiming
to contribute to broader discussions of how quality of care
may be changed in similar contexts. It has been argued
that carrying out theory-driven evaluations, including
realist evaluation and the theory-of-change approach, is
a way forward for opening the ‘black box’ and exploring
the modes of effects of complex interventions [22,23],
including within randomised controlled trials [24].
There is much variation in the concerns and methods
used by those adopting a theory-driven evaluation ap-
proach [25,26], although most propose to explicate a
theory or model of the programme/intervention and
use this to guide and strengthen evaluation questions
and analysis [27]. We set out to understand the PRIME
intervention and its actions by mapping out the intended
intervention programme and contrasting this with the
realities of implementation in practice and local inter-
pretations of intervention effects, as well as interpreting
contextual influences and attempting to assess impact
within and outside of the intended consequences of the
intervention.
Methods and analysis
Aim
The PROCESS study aims to evaluate the implementation,
mechanisms of change and context of the PRIME inter-
vention at health centres in rural Uganda to inform
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interpretation of outcomes in the main cluster-randomised
trial.
Objectives
1. To develop a comprehensive logic model of the
PRIME intervention, mapping components of the
intervention through to their intended effects
and outcomes.
2. To evaluate the implementation of the intervention,
including health worker training, health centre
management tools, and the support of supply of AL
and RDTs for malaria when stocks run low.
3. To understand mechanisms of change of the
intervention components, including testing
hypotheses and interpreting realities of intervention
components in context.
4. To develop a contextual record over time of factors
that may have affected intervention implementation,
mechanisms of change and trial outcomes, including
factors at community, health centre and
district levels.
Table 1 PRIME intervention components, modules and topics
Intervention component Module Module title Topic***
Health centre HCM 00* Introduction to HCM ▪ Accountability
Management (HCM) HCM 01* Primary Healthcare (PHC)
Fund management
▪ Budgeting and accounting using the PHC Fund management tool
▪ Budgeting and accounting – putting it all together
HCM 02 Drug Supply ▪ Principles of the drug distribution system
Management ▪ Forms required in drug distribution cycle
▪ The ACT Drug Distribution Assessment Tool (ADDAT)
HCM 03 Health Information ▪ Why quality information matters
Management ▪ The information cycle – from patient to patient
Fever case management FCM-T Fever case management training ▪ How to evaluate patients with fever and select patients
for Rapid Diagnostic testing
(FCM) ▪ Performing and reading an RDT
▪ Management of a patient with fever and a positive RDT
▪ Management of a patient with fever and a negative RDT
▪ Recognition and referral of patients with severe illness
▪ Patient education
▪ RDT storage and monitoring
FCM-S Supervision visits ▪ First supervision visit: within 1 week of training
▪ Follow-up supervision visits: 6 weeks and 6 months after initial training
Patient-centered PCS 00 Introduction to PCS ▪ Thinking about my role as a health worker
Services (PCS) ▪ Introduction to PCS
▪ Introduction to Self Observation Activities
PCS 01 Communication Skills ▪ Building Rapport
Part 1 ▪ Active listening
PCS 02 Communication Skills ▪ Asking good questions
Part 2 ▪ Giving good information
PCS 03 Building a positive work ▪ Health Centre Management Changes
environment ▪ Dealing with stress at work
PCS 04 Improving the Patient ▪ Communication Review
Visit ▪ Patient Welcome and Orientation
PCS 05** Volunteers: Improving ▪ Patient Centres Services
the Patient Visit ▪ Welcoming and greeting patients
▪ Improving patient navigation
*These two modules are to be covered in the same workshop.
**This workshop was designed for anyone working or volunteering at health centers without medical training.
***For information on learning outcomes for each module, please see the summary of training and manuals online at www.actconsortium.org.
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5. To capture broader expected and unexpected
impacts of the intervention and trial activities in
communities, public health centres, and at
private providers.
Study setting
The PRIME trial is taking place in seven sub-counties of
Tororo District, eastern Uganda. Detailed descriptions of
the health centres, population profile relating to health,
and a history of interventions in the area can be found
elsewhere [18,28]. All lower-level public health centres
in the study area (n = 22) were eligible to participate,
but due to overlapping catchment areas for two pairs
of health centres, one from each pair was randomly
excluded. A total of 10 health centres were then randomly
allocated to receive the intervention and 10 to continue
with standard care (n = 10). Further information about the
randomisation process and other details of the main trial
can be found in the trial protocol [19]. The area is highly
endemic for malaria, with an estimated 562 infective
bites per person per year [29]. The clinical focus of the
intervention was therefore on the diagnosis and man-
agement of malaria.
Study design
The PROCESS study is a mixed-method evaluation.
Figure 2 depicts our framework for the evaluation
activities. Our focus in this study is on documenting
the PRIME intervention, understanding the mechanisms
involved in the PRIME intervention in practice, and
describing the context of the PRIME intervention and
evaluation. The majority of impact evaluation activities
are being carried out under the PRIME trial [19].
Objective one: development of a logic model
The articulation of an intervention’s intended pathway of
change is recommended as a starting point for evaluation
[30]. The output of this articulation is variously referred
to as a ‘change model’ [31], ‘logic model’ [32], and ‘theory
of change’ [33]. Here, we use the term ‘logic model’
because we see it as a display of the logic specific to
this intervention trial rather than a theory that has
broader application. The logic model for the PRIME
intervention trial intends to articulate a set of hypotheses
and assumptions upon which the trial’s outcomes and
activities are based. The logic model is intended to set
out the pathway of change from the PRIME intervention
inputs through to the outcomes measured in the PRIME
evaluation, incorporating proximal mechanisms and the
conditions assumed to be required in order to support
change. The development of the logic model is intended
to be a process that can lead to refinement of intervention
design as well as guide the design of evaluation activities
[34]. Its development is therefore planned to be a dynamic
process, occurring alongside intervention development,
and involving team members involved in both the PRIME
intervention and PRIME evaluation activities.
Objective two: implementation evaluation
The implementation evaluation aims to document how
the intervention is delivered and received, and to compare
this with intended implementation. This should equip the
Figure 1 Timeline of activities for the ACT PROCESS study.
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research team to know whether trial outcomes can be
attributed to the intended intervention or if there was
implementation failure [22]. The intended implementation,
consisting of inputs, process, and outputs—elsewhere
termed ‘implementation theory’ [23], ‘process theory’
[35], or ‘action model’ [31]—will be described elsewhere,
including the rationale for the design. The implementation
will be assessed in terms of the aspects detailed in Table 2,
following Saunders et al. [36], for each of the PRIME
training intervention components (Health Centre Man-
agement, Fever Case Management, and Patient- Centered
Services).
Self-filled questionnaires
Data will be collected through self-filled questionnaires
completed by all trainers (n = 5) and participants (n = 40 –
50) after each workshop, for which written consent will
be obtained at the first workshop. Questions will elicit
yes/no responses, four-point Likert scale responses to
statements from ‘strongly agree’ to ‘strongly disagree’ and
open-ended responses. Participants will be encouraged to
complete questionnaires honestly, with no repercussions
for involvement with the project and with confidentiality
assured. Observational data will also be collected in a
non-structured format by the implementation evaluation
team during trainings, to record any aspects relevant to
fidelity of the implementation, dose delivered and received,
recruitment, and contextual factors. Finally, in-depth in-
terviews with implementers, stakeholders and health
workers will be carried out 9 to 12 months after the
training, with topic guides including questions relating
to the implementation of activities. Analysis will involve
descriptive statistics and content summaries of the open
text fields in the questionnaires. In-depth interviews will
Development 
of logic model
Description 
and mapping 
Logic Model
Implementation
evaluation
Documentation of what 
was implemented
Mechanisms evaluation
Testing hypotheses and
understanding interpretation 
Impact Evaluation
Understanding of depth 
and breadth of impact
Context Evaluation
Evaluation 
Model
Figure 2 Framework for ACT PROCESS study.
Table 2 Implementation evaluation assessment domains, questions and methods
Assessment domain Questions relating to PRIME training Data collection methods
Fidelity How much of the PRIME training was delivered as intended?
What parts were not delivered?
Trainer questionnaires; direct observations
Reach How much of the intended audience was exposed to the
PRIME training?
Participant questionnaires
Dose delivered What parts of the PRIME training were delivered most and
least successfully to participants?
Trainer questionnaires; direct observations
Dose received Which objectives, content and activities of the PRIME training
were understood/absorbed best by participants?
Participant questionnaires; direct observations
Effectiveness Did the training achieve its objectives according to proximal
outcomes for participants?
Participant questionnaires
Recruitment What procedures were necessary to encourage recruitment? Trainer questionnaires; direct observations
Context What social, logistical and political factors affected the delivery
and receipt of the PRIME training?
Trainer questionnaires; direct observations; implementer,
stakeholder and health worker in-depth interviews
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be analysed thematically, using NVivo software to code
the transcripts.
Objective three: mechanisms evaluation
The mechanisms evaluation aims to describe the ‘actual’
pathways of change from intervention inputs to measured
outcomes, enabling comparison with the intended path-
ways of change in the trial’s logic model. This will involve
two lines of questioning: first, testing hypotheses from
the logic model, evaluating whether intended mechanisms
‘work’ as planned; and second, understanding the way that
the intervention ideas, principles, and materials are taken
up, adapted, contested, rejected, and recast in context.
Hypothesis testing
The ability to test hypotheses within the intended path-
ways of change of an intervention trial is important for
the trials such as PRIME where a randomised approach
can be undermined by a long and complex pathway
from the intervention inputs delivered to health workers
and the trial outcomes at the population level [37].
Hypothesis testing enables the research team to establish
plausibility that outcomes are attributable to the action of
the intervention, rather than to other factors or a different
mechanism triggered by the intervention [38,39]. Hypoth-
esis testing also enables consideration that outcomes
are attributable to particular aspects of the intervention.
Semi-structured questionnaires
For each of the intervention components, questionnaires
will be designed for self-completion by all health workers
(n ≅ 60) and all health workers in-charge (n ≅ 20) in
both arms of the trial between 9 and 12 months after
the intervention started. The questionnaires will attempt
to assess change in line with each intended output of the
intervention through the comparison between arms of a
series of responses to statements with four-point Likert
scale response options, from ‘strongly agree’ to ‘strongly
disagree.’ Respondents will be asked to provide written
consent at the start of the questionnaire. Open-ended
questions will also be included on each topic to encourage
expansion by respondents. Questions to assess the
Health Centre Management component will ask for
health worker in-charge experiences and opinions on
financial management, stock management, and health
management information systems. Questions to assess
the proximal impact of Patient- Centred Services, will be
designed to assess ‘patient-centeredness,’ adapting a tool
tested in several Northern countries [40]. An assessment
of health worker motivation and feelings towards work
will be undertaken within the questionnaire by adapting
a tool piloted in Tanzania [41], generating scores for
‘internal motivation’ and ‘external motivation.’ Questions
about malaria case management will cover knowledge,
confidence, trust in tests, and other factors that may
hinder or support quality case management. For each
domain, aggregate scores will be created and will be
compared between arms using one-way analysis of vari-
ance. Clustering of responses by health centre will be
assessed through the intra-class correlation coefficient
and will be adjusted for in the analysis if significant (ρ
>0.1) using a random effects linear regression model in
STATA (Statacorp, Texas). Finally, health workers in
the intervention arm only will be asked to reflect on
the usefulness of the training they received from PRIME
and the frequency they used the information and skills
learned. Descriptive statistics will be used to report on
responses to each question.
Communication assessments
A key hypothesis in the PRIME intended pathway of
change is the improvement of health worker communica-
tion due to participation in the Patient-Centered Services
workshops, and the impact of this on patient or caregiver
satisfaction with the consultation, specifically with the
interpersonal skills of the health worker. We will attempt
to assess both the patient-centeredness of health worker
communication in both arms, and the satisfaction of a
subset of caregivers of children under five in both arms.
This will first involve the audio recording of consultations,
which will be rated for patient-centeredness following
domains and rating methods developed by the Patient-
Doctor Communication Group in Canada [42,43]. Second,
caregivers will be interviewed on exit from the consult-
ation and asked a series of questions following the same
domains as the audio recording rating, with questions
adapted from an existing questionnaire also developed in
Canada [44]. The questionnaire will be translated and
pretested. Responses will be allocated an aggregate score
for each domain, following the format of the recorded
consultations. The target sample size is 100 consultations
and exit interviews, spread equally across the 10 interven-
tion and 10 standard care health centres. Both health
workers and caregivers will be informed about the study
and asked to give written consent before participating. We
will repeat this communication assessment three times: at
baseline, immediately after the intervention training, and
between 9 and 12 months after the intervention. At each
time point, the same health workers will be sought out to
participate to enable within-subject consistency. Compari-
sons of scores for the consultations and exit interviews
will be drawn between arms using the same methods as
for the semi-structured questionnaires described above.
Enactment of the intervention
The ability to understand how the intervention was
interpreted and enacted by different actors is especially
important in cluster trials with relatively few units
Chandler et al. Implementation Science 2013, 8:113 Page 6 of 10
http://www.implementationscience.com/content/8/1/113
randomised to each arm; 10 in each for the PRIME trial.
Here there is potential for large between-cluster differences
in outcomes and receptiveness to interventions, which
limits interpretation of results of cluster randomised trials
[37]. An in-depth understanding of the context into which
the intervention is introduced, and of the interpretations
of the intervention by actors expected to make changes is
important to learn what was useful about the intervention,
for whom, and why. This should enable more meaningful
interpretation of the generalisability of the intervention
to different settings [24].
In our endeavour to understand how the intervention is
enacted, we are concerned with the meanings it presents
to different actors, drawing on an interpretativist per-
spective [45] as well as with the socio-material network
of resources, forms, people, and groups that enact the
intervention, drawing on a relational perspective [46].
While we are inspired by the premise of realist evalu-
ation, with an aim to understanding ‘what works, for
whom, in what circumstances, and why?’ [47], we do not
follow closely the methodology of interrogating many
potential Context-Mechanism-Outcome triads, which
assume each are bounded entities. Rather, we see the
intervention as a script that is produced or reproduced in
different activities and interactions, generating meaning
in an ongoing sense for actors engaging with it. Our
focus in this part of the PROCESS evaluation is therefore
to understand the socio-material elements that constitute
change, including but not limited to the methods, con-
tents, and materials of the PRIME intervention.
In-depth interviews
We will carry out in-depth interviews with a range of
actors to elicit narratives of the intervention and its
objectives in context, including its effects and factors
shaping interpretation and integration of its ideas, re-
sources, and processes. We will invite one health worker
per intervention health centre to be interviewed (n = 10),
as well as a range of sub-county and district representatives
from across the study area (n = 10). We will also interview
implementers of the PRIME intervention including trainers
and those involved in delivering supplies (n = 6). Interviews
will be tape-recorded, transcribed, and translated where
necessary. Transcripts will be imported into NVivo version
8 (QSR International) and coded iteratively: ideas emerging
will be labelled and grouped into themes as patterns
emerge. Particular attention will be paid to understanding
what and how changes are perceived to have occurred as
well as analysis of the way each intervention was taken up,
or not, in practice.
Focus group discussions
To understand interpretations by community members
of the PRIME intervention, which intended to impact
health outcomes through enhancing health centres, we
will carry out a series of focus group discussions (FGDs).
Two target groups from populations in the study area will
be invited: primary caregivers, representing those most
frequently visiting public health centres; and household
heads, representing those with influence over family
resources as well as those privy to local political discourses.
Three further sub-groups will be included according to
location: FGDs will be held with groups of participants
living in close proximity (within a two-kilometre radius) of
intervention health centres; in close proximity to standard
care health centres; or outside of a two-kilometre radius of
either intervention or standard care health centres. We
aim to carry out 12 FGDs following the matrix shown in
Table 3. Participants will be invited in advance, selected
with the help of local leaders, and will be asked to give
written consent prior to the start of the FGD. Discussions
will be tape-recorded and field notes will be taken.
Transcription, translation, coding, and analysis will take
place as for the in-depth interviews.
Objective four: context record
The context record aims to document information relating
to the context of the trial that may have affected the inter-
vention’s implementation, mechanisms of change, and the
outcomes under measurement. A data collection exercise
will be undertaken every three months, starting before the
intervention and ending after one year (time points = 5),
to record information sources at three levels: district
health officials (n = 5 – 10); health centre staff (n = 20);
and community representatives (n = 10 – 15, including
health assistants and lay key informants from each sub-
county). At each time point, respondents will be asked
a series of structured and open questions to elicit infor-
mation about the past three months in terms of any
(non-trial) activities, events, policies, infrastructure, human
resources, media stories, environmental or other changes
that have occurred that might have impacted: health
workers’ ability to engage with the PRIME intervention
and to provide quality care; patient and caregivers’ ability
Table 3 Sampling matrix for number of community focus group discussions
Live close (<2 km) to intervention
health centres
Live close (<2 km) to standard
care health centres
Live away (>2 km) from either intervention
or standard care facilities
Primary care givers 3 3 3
Household heads 1 1 1
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or willingness to access care at public health centres or
elsewhere; and health outcomes at the population level.
The data will be typed into Microsoft Word and
reviewed to extract relevant information into a timeline
in Microsoft Excel. Activities/events will be colour-coded
into the following categories: resources; information/
education/communication; organisation/policy; and other.
The timeline will be available to consult when results from
other sources (both quantitative and qualitative) begin
to emerge, in order to understand patterns appearing
in those data over time and between health centres and
catchment areas.
Objective five: impact evaluation
The impact evaluation component of this PROCESS study
will be a small-scale undertaking, with the aim to under-
stand some of the unintended impacts of the intervention
[48]. The main PRIME trial will evaluate the impact of
the intervention on community health outcomes. This
PROCESS protocol aims to widen the lens to evaluate
the impact of the trial on health centres, health workers,
other providers, and community members. We will add
questions to existing data collection activities listed above
as well as conducting additional data collection with
private providers.
Most significant change method
The semi-structured questionnaires, in-depth interviews,
and FGDs will begin with open questions about the most
significant change participants observed in the way they
worked/sought treatment, why this was significant, and
what difference it has made to them. This method aims
to collect and analyse systematically significant changes
from the perspectives of those involved in a programme
[49]. We will use this method to elicit broader responses
from participants, particularly stories in the in-depth
interviews and FGDs, before prompting for intended
changes and pre-defined indicators in the methods
outlined above.
Private provider questionnaires
The landscape of treatment seeking in this context
includes availability of antimalarials at private providers—
registered and unregistered shops and clinics. An under-
standing of the role these providers play and the drugs
and diagnostic abilities they have available is proposed to
assist our understanding of the pathways of change and
outcomes, as well as unintended impacts of the trial.
We will therefore carry out a mapping exercise and
interview private providers using a semi-structured
questionnaire initially with 10 providers 9 to 12 months
after the intervention and then with all providers at
drug shops identified a year later, once subsidised ACTs
become available through the Affordable Medicines Facil-
ity malaria (AMFm) mechanism in Uganda.
Quality assurance
The study team will be trained in the project objectives,
collection of high quality data [50], and good clinical prac-
tice (GCP) guidelines. Study personnel will be trained and
mentored to maintain principles for good quality research
practice throughout the research process, from the design
of tools, to field work engagements, to data management
and analysis [51]. The team will work together to devise,
pilot and revise standard operating procedures (SOPs)
for all study activities. These SOPs will be adhered to
or adapted throughout the research process. Meetings
will be held at least weekly between the field team and
investigators to identify, discuss, and resolve any issues
arising from the evaluation practice and study findings.
Clear line management will be established within the
study team, and frequent performance feedback will be
given by the study investigators to the team leader and
on to the members of the study team.
Ethics
The study protocol and information sheets have been
approved by the Ugandan National Council for Science
and Technology (UNCST Ref HS 864), the Makerere
University School of Medicine Research & Ethics
Committee (SOMREC Ref 2011–103), and the London
School of Hygiene and Tropical Medicine Ethics Com-
mittee (LSHTM Ref 5831). All potential participants
will be informed of the purpose and nature of the
study before being invited to participate and sign written
consent forms. The discussion, information sheets and
consent forms will be in the most appropriate language
for the participant—whether English, Luganda, Japadhola,
or Swahili—and a copy of the forms will be left with
the participant. Risks and benefits of participation will
be discussed and any questions relating to the research
answered. Participants will be informed that all records
will be kept as confidential as possible, with participants
being recorded and quoted by number rather than name.
However, participants will be made aware that any partici-
pation in the research study may involve a loss of privacy.
Participants will be given the option of not being quoted
at all, anonymously or otherwise, or included in any of
the analyses. If a potential participant is unable to read
or write, their fingerprint will substitute for a signature,
together with a signature from a witness to the informed
consent procedures.
Trial status
The PRIME trial field work completed in July 2013. Data
cleaning and analysis of the final community survey,
including the primary outcome for the survey and the
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overall trial, has not yet begun. The PROCESS study
field work completed in July 2013. Data analysis for the
PROCESS study has been ongoing, in order to inform
the development of lines of enquiry throughout the trial
period.
Discussion
The findings of this PROCESS study will be interpreted
alongside the PRIME study. We plan to use the MATRICS
(Method for Aggregating The Reporting of Interventions
in Complex Studies) approach to bring together complex
data from multiple sources to evaluate a complex inter-
vention [52]. This evaluation represents a significant
undertaking in addition to the main trial. The investi-
gators will attempt to assess which methods are most
informative in such evaluations of complex interventions
in low-resource settings.
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